MedTrace Logo

Microbial Testing for Caries Risk Assessment

NCT03389373 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-16

No results posted yet for this study

Summary

Specific Aims

1\) Assess CG (Cariogenic) Saliva-Check Mutans® saliva testing for identification of high caries risk patients

Conditions

  • Dental Caries

Interventions

DEVICE

GC Strep Mutans Saliva Sampling

Children who match inclusion criteria will have a saliva sample obtained which will act as a proxy for bacterial levels.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Camille V Gannam, DMD MS · University of Colorado, Denver

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
24 Months
Max Age
96 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-07-01
Completion
2018-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03389373 on ClinicalTrials.gov